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Background: Previous studies on the mortality rate of omphalocele are limited. The risk of death of non-isolated
omphalocele and that of cases of omphalocele that are diagnosed prenatally by ultrasound are unclear. This study
aimed to estimate the perinatal mortality of pregnancies with omphalocele. This study also examined the potential
risk of death of non-isolated omphalocele and that of cases that are prenatally diagnosed by ultrasound.
Methods: Data were retrieved from the national birth defects registry in China, for 1996–2006. Multinomial logistic
regression was used to calculate the adjusted odds ratios (AORs) and 95% confidence intervals (CIs) between
perinatal mortality and selected maternal and fetal characteristics.
Results: Among 827 cases of omphalocele, 309 (37.4%) cases resulted in termination of pregnancy and stillbirth,
and 124 (15.0%) cases resulted in death in the first 7 days after delivery, yielding a perinatal mortality rate of 52.4%
(95% CI: 49.0–55.8%). The late fetal death rate (LFDR) of omphalocele that was diagnosed prenatally by ultrasound
was 15.91-fold (AOR: 15.91, 95% CI: 10.18–24.87) higher than that of postnatally diagnosed cases. The LFDR of
non-isolated omphalocele was 2.64-fold (AOR: 2.64, 95% CI: 1.62–4.29) higher than that of isolated cases. For the
early neonatal death rate, neonates with non-isolated omphalocele had a 2.96-fold (AOR: 2.96, 95% CI: 1.82–4.81)
higher risk than isolated cases, but the difference between prenatal ultrasound diagnosis and postnatal diagnosis
was not significant.
Conclusions: Selected fetal characteristics are significantly associated with the perinatal risk of death from
omphalocele. Our findings suggest that improving pregnancy and delivery care, as well as management for
omphalocele are important.
Keywords: Omphalocele, Abdominal wall defects, Mortality, Perinatal outcome, Associated anomalies, Prenatal
diagnosis, UltrasoundBackground
Omphalocele is among the more common anterior ab-
dominal wall defects, and it is characterized as the absence
of abdominal muscles, fascia, and skin. With omphalocele,
there is herniation of the abdominal contents into the base
of the umbilical cord, and these contents are covered by a* Correspondence: zhujun028@163.com
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[1,2]. Previous studies have estimated that the overall
prevalence of omphalocele ranges from 2 to 3 per
10,000 births worldwide [3-10]. Omphalocele is also as-
sociated with a substantial risk of infant morbidity and
mortality, which is a severe disadvantage to the short-
and long-term life of affected newborns. Early surgical
repair can improve the prognosis and increase the sur-
vival rate of omphalocele.
Previous reports regarding the mortality rate of om-
phalocele are limited. Few studies have reported the
mortality of omphalocele using data from a large general
population based on congenital malformation registriestd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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cent studies have estimated the neonatal mortality of om-
phalocele using prenatal and neonatal databases from
certain hospitals. However, these databases were confined
to one hospital with a small number of cases, and the re-
ported estimates with a wide range did not truly present
the risk of death from omphalocele in the general popula-
tion [11-14].
Several risk factors are associated with the perinatal out-
come of pregnancies with omphalocele. As reported in
most studies, omphalocele of concurrent with chromo-
somal anomalies or other structural malformations is
more likely to be terminated electively and the fetus dies
in utero [14-17]. Routine prenatal ultrasound screening
allows identification of the majority of omphalocele early
in gestation, but a high proportion of prenatally diagnosed
cases of omphalocele end with termination of pregnancy
or intrauterine death [3,14,18-20]. Previous studies did
not independently investigate the risk of death from
omphalocele with associated malformations using pre-
natal diagnosis by ultrasound because of potential con-
founding effects. The magnitude of effect estimates for
the risk of death from non-isolated omphalocele and
prenatally diagnosed cases by ultrasound has been im-
precisely assessed.
This study aimed to estimate the perinatal mortality of
omphalocele using consecutive data for 11 years from the
national birth defects registry. We also aimed to examine
the potential risk of death of fetuses and neonates with
omphalocele by comparing the outcomes from different
groups (non-isolated vs isolated groups and prenatal ultra-
sound diagnosis group vs postnatal diagnosis group).
Methods
Ascertainment of cases
Data on cases with omphalocele were obtained from the
Chinese Birth Defects Monitoring Network (CBDMN)
from January 1996 to September 2006. This network is a
nationwide and hospital-based birth defects surveillance
network covering a total of 450–471 hospitals (county
level, city level, and provincial level) in China. The number
of monitored births accounted for approximately 8–10%
of the annual births in China [21]. The CBDMN used the
passive case ascertainment method to identify congenital
malformations, including live births, stillbirths, and ter-
mination of pregnancy in the member hospitals. The sur-
veillance period for each abnormality was from 28 weeks
of gestations to the first 7 days after birth. These cases
were recognized by physical examination by trained ob-
stetric and pediatric clinicians. The cases were confirmed
by documentation of the postnatal diagnosis and narrative
descriptions of abnormalities in the medical records. Cases
diagnosed by prenatal ultrasonography were also con-
firmed by the postnatal records after delivery. A trainedmidwife was then asked to complete the “Birth Defects
Register Form” registry and conduct online reporting
quarterly, after which CBDMN staff reviewed all of these
forms again. Incomplete forms and a nonspecific diagnosis
were controlled by the midwives within 7 days to correct
the final information. Pregnancies ending in stillbirth or
elective termination, including an autopsy report where
available, were reviewed to confirm or amend the final
diagnosis. Written informed consent was obtained from
the parents of neonates before they were discharged from
the hospital. The consent mainly included the aims and
importance of monitoring birth defects. This study was
approved by the Ethic Review Committee of Sichuan
University.
According to the International Clearinghouse for Birth
Defects Monitoring Systems, omphalocele was defined as
a midline abdominal wall defect, which was limited to an
open umbilical cord. The viscera herniates into the base of
the umbilical cord and is surrounded by the peritoneum
and amniotic membranes [22]. The International Classifi-
cation of Diseases, Tenth Revision, was used to code the
diagnosis for omphalocele (Q79.2) in the national birth
defects registry of China.
Permission was authored by National Health and Family
Planning Commission to access data from the CBDMN.
Data for this analysis were extracted based on the diagno-
sis code from the national birth defects registry that was
developed by the CBDMN. The following variables were
considered in our analysis: geographical location, maternal
residence, maternal age, maternal education, gestational
age, birthweight, presence or absence of other anomalies,
prenatal or postnatal diagnosis, and the year of birth. Geo-
graphical location was divided into coastal areas, inland
areas, and remote areas. Maternal age was categorized as
20–24 years old, 25–29 years old, 30–34 years old, and
35–39 years old. Residence referred to that of the mothers,
and was divided into rural (countries or suburban areas)
and urban (towns or cities) areas. Gestational age was di-
vided into 28–36 weeks and 37–42 weeks. Birthweight
was grouped into <2500 g and ≥2500 g. Isolated omphalo-
cele was defined as omphalocele, which occurred without
chromosomal or structural malformations. Non-isolated
omphalocele was defined as cases with associated chromo-
somal or structural malformations, which were not related
to omphalocele. Prenatal diagnosis refers to cases of om-
phalocele that were detected prenatally by ultrasound.
Postnatal diagnosis refers to cases of omphalocele that
were detected by physical examination after birth. The re-
sponse variable was perinatal mortality of birth with om-
phalocele, which was categorized into late fetal death
(LFD) and early neonatal death (ENND). LFD was defined
as the death of a fetus later than the gestational age of
28 weeks. ENND was defined as the death of a neonate in
the first 7 days of life. Data on the mortality of affected
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defects registry.
Data quality management
Data quality management (DQM) was routinely evalu-
ated for surveillance data. The DQM teams consisted of
five upper-level CBDMN experts. These experts verified
data collection, data reporting, diagnosis of defects, and
obstetric and pediatric medical records according to the
surveillance manual. This was performed to improve the
accuracy, comparability, completeness, and timeliness of
the registered data. For DQM at the county level, all of
the member hospitals were investigated quarterly. For
DQM at the provincial and national levels, cluster sam-
pling covered approximately one-third and 10% of the
member hospitals, respectively. Provincial- and national-
level DQM were conducted semi-annually and annually,
respectively. The under-reporting rate of live births or
malformations needed to be no greater than 1%, and er-
rors or missing information on the report form had to
be no greater than 1%. At each level, a panel of senior
health professionals evaluated the completeness, accur-
acy, and timeliness of the data.
Statistical analysis
The perinatal mortality rate of omphalocele was the sum
of the late fetal death rate (LFDR) and early neonatal
death rate (ENNDR). The LFDR was calculated by the
number of stillbirths and termination of pregnancies di-
vided by the total number of births with omphalocele.
The ENNDR was calculated by the number of neonatal
deaths within the first 7 days after birth divided by the
total number of births with omphalocele.
The Cochran–Armitage trend test was used to assess
the changes in mortality of omphalocele over time. Be-
cause the response variables in our analysis were nominal
and for which there were two categories, multinomial lo-
gistic regression was used to generate the odds ratios and
95% confidence intervals (CIs) between the rate of LFD/
ENND and selected maternal/fetal characteristics, while
controlling for confounding factors to evaluate the effect
of each variable. The estimated risks were adjusted by
potential confounders, which were selected on the basis
of the results of the bivariate analysis and previously re-
ported evidence. All tests of hypotheses were two-tailed
with a type 1 error rate fixed at 5%. Statistical analyses
were performed using SAS 9.1 software (SAS Institute
Inc., Cary, NC).
Since September 2006, the number of the member
hospitals has almost doubled. Therefore, to ensure the
comparability of registered data from the member hospi-
tals, our study period was confined to January 1996 to
September 2006. During the study period, because the
number of births in some of the sampled surveillancehospitals had declined, we increased the number of hos-
pitals that were selected from neighboring counties to
monitor a sufficient amount of births to ensure a repre-
sentative sampled population. Additionally, some of the
member hospitals were replaced by other neighboring
hospitals because of reorganization of their medical ser-
vices. Therefore, the number of hospitals over the study
period changed in our analysis.
Results
From January 1996 to September 2006, a total of 827
cases of omphalocele were identified from the CBDMN,
which included termination of pregnancy, stillbirths, and
live births. Of these, 322 (39.3%) cases were diagnosed
antenatally by ultrasound and 501 cases (60.6%) were con-
firmed by physical examination after birth. Four cases had
missing diagnosis information. Among the 827 cases, iso-
lated omphalocele occurred in 596 (72.1%) cases and 231
(27.9%) cases were non-isolated omphalocele. The most
commonly associated anomaly with omphalocele was cleft
lip with or without cleft palate or cleft palate (n = 45),
followed by neural tube defects (n = 36), and then polydac-
tyly or syndactyly (n = 33).
The perinatal mortality of pregnancies with omphalo-
cele is shown in Table 1. A total of 309 fetuses died after
28 weeks’ gestation and 124 neonates were dead within
the first 7 days after birth. The perinatal mortality rate,
LFDR, and ENNDR of omphalocele was 52.4% (95% CI:
49.0–55.8%), 37.4% (95% CI: 34.1–40.7%), and 15.0%
(95% CI: 12.6–17.4%), respectively. The risk of death of a
fetus was nearly 2.5 times higher compared with that of
a neonate.
Over the study period, there were annual fluctuations
for the ENNDR. The highest rate was in 1996 (26.8%,
95% CI: 15.2–38.4%) and the lowest was in 2004 (5.0%,
95% CI: 0.7–9.2%). There was a significant difference in
the annual ENNDR (p < 0.05) during the study period,
but not for the LFDR (p > 0.05) and perinatal mortality
rate (p > 0.05). Furthermore, an upward trend was observed
for the LFDR but a downward trend was observed for the
ENNDR for 1996–2006, using the Cochran-Armitage trend
test (both p < 0.05). In contrast, no trend was shown for
the perinatal mortality rate (p > 0.05).
Table 2 shows the association between the mortality of
fetuses or neonates and selected maternal characteristics.
Fetuses or neonates with omphalocele who were located
in inland areas had a 1.56-fold or 1.72-fold higher mortal-
ity than those in coastal areas [adjusted odds ratio (AOR):
1.56, 95% CI: 1.09–2.24; AOR: 1.72, 95% CI: 1.03–2.85, re-
spectively]. However, there was no significant difference in
mortality for the LFDR or ENNDR in remote areas com-
pared with coastal areas (AOR: 1.07, 95% CI: 0.73–1.57;
AOR: 1.53, 95% CI: 0.91–2.59, respectively). Neonates
born to mothers with primary school or unschooled
Table 1 Perinatal mortality of pregnancies with omphalocele from 1996 to 2006, China
Years Total
N
Late fetal death Early neonatal death Perinatal mortality
No. Rate* (95% CI) No. Rate* (95% CI) No. Rate* (95% CI)
1996 56 19 33.9 (21.5, 46.3) 15 26.8 (15.2, 38.4) 34 60.7 (47.9, 73.5)
1997 46 19 41.3 (27.1, 55.5) 8 17.4 (6.4, 28.3) 27 58.7 (44.5, 72.9)
1998 71 19 26.8 (16.5, 37.1) 9 12.7 (4.9, 20.4) 28 39.4 (28.1, 50.8)
1999 83 29 34.9 (24.7, 45.2) 10 12.1 (5.0, 19.1) 39 47.0 (36.3, 57.7)
2000 83 30 36.1 (25.8, 46.5) 15 18.1 (9.8, 26.4) 45 54.2 (43.5, 64.9)
2001 67 19 28.4 (17.6, 39.2) 11 16.4 (7.6, 25.3) 30 44.8 (32.9, 56.7)
2002 75 28 37.3 (26.4, 48.3) 12 16.0 (7.7, 24.3) 40 53.3 (42.0, 64.6)
2003 66 20 30.3 (19.2, 41.4) 16 24.2 (13.9, 34.6) 36 54.6 (42.5, 66.6)
2004 101 45 44.6 (34.9, 54.3) 5 5.0 (0.7, 9.2) 50 49.5 (39.8, 59.3)
2005 115 53 46.1 (37.0, 55.2) 16 13.9 (7.6, 20.2) 69 60.0 (51.1, 69.0)
2006 64 28 43.8 (31.6, 55.9) 7 10.9 (3.3, 18.6) 35 54.7 (42.5, 66.9)
Total 827 309 37.4 (34.1, 40.7) 124 15.0 (12.6, 17.4) 433 52.4 (49.0, 55.8)
*Rate is the number of death per 100 fetus and neonates with omphalocele from 28 weeks of gestations to the first 7 days of life.
CI, confidence interval.
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with those born to mothers who had gone to high
school (AOR: 2.76, 95% CI: 1.35–5.63), whereas this
phenomenon did not occur with the LFDR (AOR: 0.89,




No. Rate* (95% CI) COR (95% CI)
Geographical location
Coastal areas 308 108 35.1 (29.7, 40.4) Ref.
Inland areas 285 121 42.5 (36.7, 48.2) 1.55 (1.09, 2.20)
Remote areas 234 80 34.2 (28.1, 40.3) 1.07 (0.73, 1.56)
Maternal residence
Urban 518 190 36.7 (32.5, 40.8) Ref.
Rural 309 119 38.5 (33.1, 43.9) 1.29 (0.94, 1.76)
Maternal age$ (years)
20–24 277 104 37.5 (31.8, 43.2) 1.12 (0.79, 1.58)
25–29 358 135 37.7 (32.7, 42.7) Ref.
30–34 131 47 35.9 (27.7, 44.1) 0.87 (0.57, 1.35)
35–39 59 22 37.3 (24.9, 49.6) 0.88 (0.49, 1.59)
Maternal education#
Primary school/unschooled 121 40 33.1 (24.7, 41.4) 1.07 (0.65, 1.76)
Junior school 337 125 37.1 (31.9, 42.2) 1.06 (0.74, 1.52)
High school 231 90 39.0 (32.7, 45.2) Ref.
More than high school 131 50 38.2 (29.8, 46.5) 0.95 (0.60, 1.50)
*Rate is the number of death per 100 fetus and neonates with omphalocele from 2
†ORs were adjusted by geographical location, maternal residence, maternal age, an
$Two cases with unregistered maternal age were excluded in this analysis. Group o
was also combined into group of 35–39 years because of the small number of case
#Seven cases with unknown maternal education were excluded in this analysis.
COR, crude odds ratio; AOR, adjusted odds ratio; CI, confidence interval; Ref., refereborn to mothers with more than high school education
were not significantly different from those born to
mothers with high school education (AOR: 0.97, 95%
CI: 0.61–1.54; AOR: 0.97, 95% CI:0.45–2.09, respectively).
Neonates of women who resided in rural areas had athe selected maternal characteristics, China, 1996-2006
Early neonatal death
AOR† (95% CI) No. Rate* (95% CI) COR (95% CI) AOR† (95% CI)
Ref. 37 12.0 (8.4, 15.6) Ref. Ref.
1.56 (1.09, 2.24) 46 16.1 (11.9, 20.4) 1.72 (1.05, 2.81) 1.72 (1.03, 2.85)
1.07 (0.73, 1.57) 41 17.5 (12.7, 22.4) 1.60 (0.97, 2.65) 1.53 (0.91, 2.59)
Ref. 63 12.2 (9.3, 15.0) Ref. Ref.
1.34 (0.91, 1.97) 61 19.7 (15.3, 24.2) 1.99 (1.32, 3.00) 1.32 (0.81, 2.18)
1.05 (0.73, 1.52) 54 19.5 (14.8, 24.2) 1.57 (1.00, 2.46) 1.16 (0.72, 1.88)
Ref. 50 14.0 (10.4, 17.6) Ref. Ref.
0.90 (0.58, 1.41) 15 11.5 (6.0, 16.9) 0.75 (0.40, 1.43) 0.70 (0.36, 1.35)
0.90 (0.50, 1.63) 5 8.5 (1.4, 15.6) 0.54 (0.20, 1.46) 0.50 (0.18, 1.37)
0.89 (0.51, 1.56) 32 26.4 (18.6, 34.3) 3.35 (1.78, 6.30) 2.76 (1.35, 5.63)
0.93 (0.62, 1.39) 57 16.9 (12.9, 20.9) 1.89 (1.10, 3.24) 1.66 (0.93, 2.99)
Ref. 23 10.0 (6.1, 13.8) Ref. Ref.
0.97 (0.61, 1.54) 12 9.2 (4.2, 14.1) 0.89 (0.42, 1.91) 0.97 (0.45, 2.09)
8 weeks of gestations to the first 7 days of life.
d maternal education.
f <20 years was combined into group of 20–24 years and group of ≥40 years
s in these groups.
nce group.
Deng et al. BMC Pediatrics 2014, 14:160 Page 5 of 7
http://www.biomedcentral.com/1471-2431/14/160higher risk of LFD or ENND than those of women in
urban areas, but this difference was not significant
(AOR: 1.34, 95% CI: 0.91–1.97; AOR: 1.32, 95% CI:
0.81–2.18, respectively). Similarly, the mortality of fe-
tuses or neonates born to women in the lower maternal
age groups had a higher risk of death compared with
those born to women in the higher maternal age groups,
but this difference was not significant.
Table 3 shows the association between the mortality of
omphalocele-affected pregnancies and selected fetal
characteristics. The LFDR at the gestational ages of 28–36
weeks was 2.42-fold higher than that of 37–42 gestational
weeks (AOR: 2.42, 95% CI: 1.52–3.86). Additionally, birth-
weight of <2500 g was 3.17-fold higher, non-isolated om-
phalocele was 2.64-fold higher, and diagnosis by prenatal
ultrasound was 15.91-fold higher compared with birth-
weight of ≥2500 g, isolated omphalocele, and diagnosis by
postnatal ultrasound, respectively (AOR: 3.17, 95% CI:
1.97–5.09; AOR: 2.64, 95% CI: 1.62–4.29; AOR: 15.91,
95% CI: 10.18–24.87, respectively). The LFDR of om-
phalocele that was diagnosed by prenatal ultrasound
was the highest, followed by <2500 g birthweight, and
then non-isolated omphalocele. Neonates with <2500 g
birthweight and non-isolated omphalocele had a higher
ENNDR than that of the reference groups (AOR: 1.72,
95% CI: 1.04–2.82; AOR: 2.96, 95% CI: 1.82–4.81, re-
spectively). The mortality of neonates who were born at
28–36 gestational weeks and the LFDR of cases of pre-
natally diagnosed omphalocele were slightly higher than
those of the reference groups, but these differences were
not significant (AOR: 1.18, 95% CI: 0.72–1.96; AOR:
1.42, 95% CI: 0.81–2.50, respectively). Neonates with
omphalocele and non-isolated abnormalities had the
highest rate of death in the first 7 days of life, followed
by neonates who were <2500 g birthweight at birth.
Discussion
We found that the perinatal mortality of pregnancies
with omphalocele was 52.4%, late fetal mortality was
37.4%, and early neonatal mortality was 15.0%. These es-
timates are in line with previous research showing that
39–41% of cases of omphalocele result in termination of
pregnancy and stillbirth, and 12% of cases result in neo-
natal death [4,5]. However, higher estimates than our re-
sults have been reported in other birth defects registries
[6,9,12,18,23,24]. The inconsistency in the mortality rate
for omphalocele may be owing to the registered gesta-
tional weeks of pregnancy, prenatal detection, follow-up
period, and prenatal and postnatal care, as well as man-
agement of omphalocele.
After controlling for confounding factors, we observed
that prenatally diagnosed omphalocele was more likely
to result in LFD compared with non-isolated omphalo-
cele. This finding is supported by previous studies onthe perinatal outcome of fetal omphalocele following
prenatal diagnosis [12,14,20]. However, most of these
previous results were mixed by the effect of non-isolated
and prenatal diagnosis, showing that a high proportion
of omphalocele was prenatally diagnosed by ultrasound,
and fetuses were electively terminated or died in utero.
If parents were properly counseled by a pediatrician
and intrauterine transfer occurred to tertiary units with
pediatric surgical facilities, the outcome of prenatally diag-
nosed omphalocele would be more favorable [13].
For neonates within 7 days old, those with non-isolated
omphalocele had a higher risk of death than prenatally
diagnosed cases. Up to 70% of omphalocele cases are as-
sociated with other structural malformations, chromo-
somal abnormalities, and genetic syndromes, and this
phenomenon is significantly associated with the ultim-
ate prognosis for these fetuses [15,25-27]. In addition,
prenatal ultrasound diagnosis did not significantly in-
crease the risk of death of a neonate in early life, with
similar results found in another study [20]. This finding
can be explained by the following two points. First, pre-
natal ultrasonography has become a routine examination
in pregnancy. The sensitivity of prenatal ultrasound screen-
ing in detecting omphalocele is 75% in the second trimester
of pregnancy, ranking second among all of the congenital
malformations that are diagnosed prenatally by ultrasound
(anencephaly is the first) [24,28]. Second, prenatally diag-
nosed cases include more fetuses with a giant omphalo-
cele or liver herniation compared with those postnatally
diagnosed, and most women opt for termination of preg-
nancy or intrauterine death occurs [20].
There are several limitations to our study. First, we could
not distinguish between termination of pregnancy from
stillbirth in our analysis. Therefore, we could not estimate
the proportion of electively terminated pregnancies and
the proportion of stillbirths. Second, our monitoring period
covered the period from 28 gestational weeks to the first
7 days after delivery. This means that we did not investi-
gate the death of fetuses before the age of 28 gestational
weeks. Consequently, our reported mortality may under-
estimate the true risk of death from omphalocele. Third,
because some women who had fetuses with omphalocele
terminated pregnancy or death occurred in utero, they re-
fused an autopsy. Therefore, the characteristics of these
cases could not be verified postnatally, resulting in the
misclassification of other associated anomalies as isolated
omphalocele and the misclassification of gastroschisis and
other abdominal wall defects as omphalocele. Finally, be-
cause this study was hospital-based and it focused on se-
lected hospitals rather than all deliveries in a region, the
hospital-based samples may have introduced referral bias.
However, because of the wide geographic coverage, con-
sistent case ascertainment, and the large sample size, the
CBDMN data used in our study were reliable.
Table 3 Association with perinatal mortality of omphaloceles by the selected fetal characteristics, China, 1996-2006
Total
N
Late fetal death Early neonatal death
No. Rate* (95% CI) COR (95% CI) AOR† (95% CI) No. Rate * (95% CI) COR (95% CI) AOR† (95% CI)
Gestational age$ (weeks)
37–42 436 83 19.0 (15.4, 22.7) Ref. Ref. 74 17.0 (13.4, 20.5) Ref. Ref.
28–36 388 224 57.7 (52.8, 62.6) 6.61 (4.73, 9.22) 2.42 (1.52, 3.86) 50 12.9 (9.6, 16.2) 1.65 (1.09, 2.52) 1.18 (0.72, 1.96)
Birthweight# (g)
≥2500 428 80 18.7 (15.0, 22.4) Ref. Ref. 65 15.2 (11.8, 18.6) Ref. Ref.
<2500 395 226 57.2 (52.3, 62.1) 7.20 (5.15, 10.83) 3.17 (1.97, 5.09) 58 14.7 (11.2, 18.2) 2.28 (1.50, 3.45) 1.72 (1.04, 2.82)
Non-isolated omphalocele
No 596 198 33.2 (29.4, 37.0) Ref. Ref. 76 12.8 (10.1, 15.4) Ref. Ref.
Yes 231 111 48.1 (41.6, 54.5) 2.51 (1.78, 3.54) 2.64 (1.62, 4.29) 48 20.8 (15.5, 26.0) 2.82 (1.81, 4.40) 2.96 (1.82, 4.81)
Prenatal ultrasound diagnosis§
No 498 70 14.1 (11.0, 17.1) Ref. Ref. 99 19.9 (16.4, 23.4) Ref. Ref.
Yes 322 235 73.0 (68.1, 77.8) 17.81 (12.17, 26.06) 15.91 (10.18, 24.87) 25 7.8 (4.8, 10.7) 1.34 (0.80, 2.25) 1.42 (0.81, 2.50)
*Rate is the number of death per 100 fetus and neonates with omphalocele from 28 weeks of gestations to the first 7 days of life.
†ORs were adjusted by geographical location, maternal residence, maternal age, maternal education, gestational age, birthweight, non-isolated omphalocele and diagnosis by prenatal ultrasonography.
$Three cases with unknown gestation age were excluded from this analysis.
#Four cases with unknown birthweight were excluded from this analysis.
§Seven cases with unknown prenatal ultrasound diagnosis were excluded from this analysis.
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Our findings contribute to the growing body of estimates
regarding perinatal mortality in fetuses and neonates with
omphalocele. Cases of prenatally diagnosed omphalocele
have a higher risk of LFD, while there is no significant risk
of death for neonates with omphalocele when they are di-
agnosed prenatally. Those with non-isolated omphalocele
are more likely to die in the early neonatal period. Improv-
ing pregnancy and delivery care, as well as management
for omphalocele are important. Further studies are needed
to include more current data to investigate the perinatal
mortality of pregnancies with omphalocele.
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